INCREMENTAL INNOVATION
CLIENT: IFPMA
Founded in 1968, the IFPMA is a global, non-profit, nongovernmental organization. With members across the globe and a secretariat based in Geneva, Switzerland, the IFPMA represents the research-based pharmaceutical industry, including the biotechnology and vaccine sectors.
Our members comprise leading international companies as well as national and regional industry pharmaceutical associations in both developing and developed countries. Our primary role is to improve global health by representing our members in dialogue with intergovernmental bodies, nongovernmental organizations, Geneva-based missions of national governments, civil society organizations and others.
Incremental innovation widens treatment options available to healthcare providers and adapts medicines better to patients’ needs. This process is marked by expanding the number of medicines within a therapeutic class, increasing the number of available dosing options, discovering new physiological interactions, and improving other properties of existing medicines. Such innovations often require as much research and development (R&D) and clinical trial investments as first-in-class medicines. – See more at: http://www.ifpma.org/innovation/ip-rights/incremental-innovation.html#sthash.Q2dSjkA3.dpuf
- Concept development
- Design
- Illustration
- Production
- Scripting
- Storyboard
- VO recording
